Vistagen Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Vistagen Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q3 2025.
  • Vistagen Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 35.7M shares, a 16.7% increase year-over-year.
  • Vistagen Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 30.9M shares, a 59.5% increase from 2023.
  • Vistagen Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 19.4M shares, a 178% increase from 2022.
  • Vistagen Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 6.96M shares.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)

Vistagen Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 35.7M +5.12M +16.7% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-13
Q2 2025 31.9M +1.33M +4.34% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 30.9M +11.5M +59.5% Jan 1, 2025 Mar 31, 2025 10-K 2025-06-17
Q4 2024 30.7M +1.32M +4.51% Oct 1, 2024 Dec 31, 2024 10-Q 2025-02-13
Q3 2024 30.6M +20.6M +205% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-13
Q2 2024 30.6M +23.3M +317% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 19.4M Jan 1, 2024 Mar 31, 2024 10-K 2025-06-17
Q4 2023 29.4M Oct 1, 2023 Dec 31, 2023 10-Q 2025-02-13
Q3 2023 10M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 7.34M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q4 2015 1.77M +463K +35.6% Oct 1, 2015 Dec 31, 2015 10-Q 2016-02-16
Q3 2015 1.62M +325K +25% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-16
Q1 2015 1.47M +304K +26.1% Jan 1, 2015 Mar 31, 2015 10-K 2016-06-24
Q4 2014 1.3M +192K +17.3% Oct 1, 2014 Dec 31, 2014 10-K 2016-06-24
Q3 2014 1.3M +171K +15.2% Jul 1, 2014 Sep 30, 2014 10-K 2016-06-24
Q2 2014 1.23M +168K +15.8% Apr 1, 2014 Jun 30, 2014 10-K 2016-06-24
Q1 2014 1.16M -19.1M -94.3% Jan 1, 2014 Mar 31, 2014 10-K 2015-06-29
Q4 2013 1.11M -17.2M -93.9% Oct 1, 2013 Dec 31, 2013 10-K 2015-06-29
Q3 2013 1.13M -16M -93.4% Jul 1, 2013 Sep 30, 2013 10-K 2015-06-29
Q2 2013 1.06M -15.8M -93.7% Apr 1, 2013 Jun 30, 2013 10-K 2015-06-29
Q1 2013 20.2M +3.69M +22.3% Jan 1, 2013 Mar 31, 2013 10-K 2013-07-18
Q4 2012 18.3M +2.26M +14.1% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 17.1M +1.85M +12.2% Jul 1, 2012 Sep 30, 2012 10-K 2013-07-18
Q2 2012 16.8M +5.74M +51.7% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 16.5M +11.3M +216% Jan 1, 2012 Mar 31, 2012 10-K 2013-07-18
Q4 2011 16M +10.8M +206% Oct 1, 2011 Dec 31, 2011 10-K 2013-07-18
Q3 2011 15.2M +10M +191% Jul 1, 2011 Sep 30, 2011 10-K 2013-07-18
Q2 2011 11.1M +5.87M +112% Apr 1, 2011 Jun 30, 2011 10-K 2013-07-18
Q1 2011 5.24M Jan 1, 2011 Mar 31, 2011 10-K 2012-07-02
Q4 2010 5.24M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q3 2010 5.24M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 5.24M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-22

Vistagen Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 30.9M +11.5M +59.5% Apr 1, 2024 Mar 31, 2025 10-K 2025-06-17
2023 19.4M +12.4M +178% Apr 1, 2023 Mar 31, 2024 10-K 2025-06-17
2022 6.96M Apr 1, 2022 Mar 31, 2023 10-K 2024-06-11
2015 1.77M +449K +34.1% Apr 1, 2015 Mar 31, 2016 10-K 2016-06-24
2014 1.32M +220K +20% Apr 1, 2014 Mar 31, 2015 10-K 2016-06-24
2013 1.1M -19.7M -94.7% Apr 1, 2013 Mar 31, 2014 10-K 2015-06-29
2012 20.8M +6.1M +41.4% Apr 1, 2012 Mar 31, 2013 10-Q 2014-08-12
2011 14.7M +9.5M +181% Apr 1, 2011 Mar 31, 2012 10-K 2013-07-18
2010 5.24M Apr 1, 2010 Mar 31, 2011 10-K 2012-07-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.